The tumor suppressor PTEN acts as a regulator of AKT activity by dephosphorylating PIP3, although it is frequently downregulated or lost during tumor progression, contributing to deregulation of the pathway in cancer cells. This evidence concerns the gene PTEN and neoplasm.